Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs

Drug Development and Industrial Pharmacy

Volumn 34, Issue 6, 2008, Pages 569-576

  Tian, Lingling ^a   Zhang, Yu ^a   Tang, Xing ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Eudragit NE30D; Opadry I; Subcoat; Sustained release pellet; Wax matrix

Indexed keywords

EUDRAGIT; OCTADECANOL; OPADRY; POLYMER; VENLAFAXINE; WAX;

ARTICLE; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG FORMULATION; DRUG PELLET; DRUG RELEASE; DRUG SOLUBILITY; DRUG STORAGE; DRUG SYNTHESIS; FLUIDIZED BED REACTOR; SPHERONIZATION; SUSTAINED RELEASE PREPARATION;

ANTIDEPRESSIVE AGENTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOHEXANOLS; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; DRUG STORAGE; EXCIPIENTS; FATTY ALCOHOLS; KINETICS; METHACRYLATES; MICROSCOPY, ELECTRON, SCANNING; POLYMERS; SOLUBILITY; TABLETS, ENTERIC-COATED; TEMPERATURE; WAXES;

EID: 45849145426     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701831702     Document Type: Article

References (24)

1. Allen, L. V., Allen, J., Popovich, N. G., & Ansel, H. C. (2005). Ansel's pharmaceutical dosage forms and drug delivery systems (8th ed.). Philadelphia: Lippincott Williams & Wilkins.
2. Bergstrand, P., & Wang, P. (2002). Pharmaceutical formulation comprising omeprazole. U.S. Patent 6428810.
3. Diane, B. L., Koleng, J. J., & McGinity, J. W. (2003). The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets. Drug Dev. Ind. Pharm., 29, 909-924.
4. Diane, B. L., Petereit, H., Beckert, T., & McGinity, J. W. (2003). Properties of enteric coated sodium valproate pellets. Int. J. Pharm., 264, 85-96.
5. Ford, J. L., Mitchell, K., Sawh, K., Ramdour, S., Armstrong, D., & Elliott, P. N. C., et al. (1991). Hydroxypropylmethylcellulose matrix tablets containing propranolol hydrochloride and sodium dodecyl sulphate. Int. J. Pharm., 71, 213-221.
6. Ghebre-sellassie, I., Gordon, R. H., Nesbitt, R. U., & Fawzi, M. B. (1987). Evaluation of acrylic-based modified-release film coatings. Int. J. Pharm., 37, 211-218.
7. Göran, F., Åsa, T., & Göran, A. (2003). Modelling of drug release from coated granular pellets. J. Control. Release, 92, 113-123.
8. Hamdani, J., Moës, A. J., & Amighi, K. (2002). Development and evaluation of prolonged release pellets obtained by the melt pelletization process. Int. J. Pharm., 245, 167-177.
9. Heng, P. W. S., Hao, J., Chan, L. W., & Chew, S. H. (2004). Influences of osmotic agents in diffusion layer on drug release from multilayer coated pellets. Drug Dev. Ind. Pharm., 30, 213-220.
10. Hjärtstam, J., Borg, K., & Lindstedt, B. (1990). The efect of tensile stress on permeability of free films of ethyl cellulose containing hydroxypropyl methylcellulose. Int. J. Pharm., 61, 101-107.
11. Li, S. P., Feld, K. M., & Kowarski, C. R. (1997). The effect of polymer coating systems on the preparation, tableting and dissolution properties of sustained-release drug pellets. Drug Dev. Ind. Pharm., 23, 623-631.
12. Li, S. P., Mehta, G. N., Buehler, J. D., Grim, W. M., & Harwood, R. J. (1990, April). The effect of film-coating additives on the in vitro dissolution release rate of ethyl cellulose-coated theophylline granules. Pharmaceutical Technology International, 48-52.
13. Lovgren, K., I., Pilbrant, A., G., Yasumura, M., Morigaki, S., Oda, M., & Ohishi, N. (1988). Pharmaceutical preparation for oral use. U.S. Patent 4786505.
14. Mine, Ö., Evren, H., & Gökhan, E. (2006). Release and diffusional modeling of metronidazole lipid matrices. Eur. J. Pharm. Biopharm., 63, 331-339.
15. Otsuka, M., & Matsuda, Y. (1994). Effect of cogrinding time on the release of pentoxyfylline from waxy matrix tablets. J. Pharm. Sci., 86, 929-934.
16. Ozturk, A. G., Ozturk, S. S., Palsson, B. O., Wheatley, T. A., & Dressman, J. B. (1990). Mechanism of release from pellets coated with an ethylcellulose-based film. J. Control. Release, 14, 203-213.
17. Porter, S. C., & Woznicki, E. J. (1985). Dry edible film coating composition, method and coating form. U.S. Patent 4543370.
18. Rahman, N. U., & Yuen, K. H. (2005). Eudragit NE40-drug mixed coating system for controlling drug release of core pellets. Drug Dev. Ind. Pharm., 31, 339-347.
19. Rekhi, G., Porter, S., & Jambhekar, S. (1995). Factors affecting the release of propanolol hydrochloride from beads coated with aqueous polymeric dispersions. Drug Dev. Ind. Pharm., 21, 709-729.
20. Ritger, P. L., & Peppas, N. A. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Control. Release, 5, 37-42.
21. Sadeghi, F., Ford, J. L., Rubinstein, M. H., & Rajabi-Siahboomi, A. R. (2000). Comparative study of drug release from pellets coated with HPMC or surelease. Drug Dev. Ind. Pharm., 26, 651-660.
22. Sato, H., Miyagawa, Y., Okabe, T., Miyajima, M., & Sunada, H. (1997). Dissolution mechanism of diclofenac sodium from wax matrix granules. J. Pharm. Sci., 86, 929-934.
23. Sherman, D. M., Clark, J. C., Lamer, J. U., & White, S. A. (2002). Extended release formulation of venlafaxine hydrochloride. U.S. Patent 6419958.
24. Umprayn, K., Chitropas, P., & Amarekajorn, S. (1999). Development of terbutaline sulfate sustained-release coated pellets. Drug Dev. Ind. Pharm., 25, 477-491.